Cerament G Shows Outstanding Long-term Results
Mid- to long-term data confirmed sustained clinical effectiveness of CERAMENT G in a single-stage protocol to manage chronic osteomyelitis. Sep 12, 2022
First Patient Treated in Spine BioPharma Phase III Clinical Study
SB-01 intradiscal pharmacologic treatment is in Phase III studies for the treatment of pain-related disability associated with degenerative disc disease. Sep 08, 2022
Bioretec’s Hybrid Composite Patent Approved in Europe
The patent, addressing hybrid composite material, will be used in Bioretec's RemeOs product family that require very high load-bearing capacity. Sep 08, 2022
Novarad Secures Distribution Network in the U.S.
The neurosurgical and spine distribution partners bring broad experience to support the growth of Novarad's VisAR and OpenSight product lines. Sep 08, 2022
Research Update: Premia Spine’s TOPS Spinal Joint Replacement
The TOPS spinal joint replacement has shown potential to relieve back pain and maintain mobility without adjacent level degeneration. Sep 07, 2022
First Case with Centinel Spine prodisc C Total Disc
Centinel Spine has four FDA-approved 1-level cervical total disc replacement devices, and a portfolio that allows matching the disc to patient anatomy. Sep 07, 2022
SeaSpine Launches WaveForm TA Interbody
The system delivers an interbody to the anterior portion of the disc space to optimize sagittal alignment and endplate support. Sep 07, 2022
Life Spine Hits Milestone Sales of Micro Invasive Expandable Implants
Life Spine’s Micro Invasive expandable portfolio comprises solutions for PLIF, TLIF, Lateral and ISP Fixation. Sep 06, 2022
CurveBeam & StraxCorp Merge to Form CurveBeam AI
CurveBeam AI expands CurveBeam's financially viable point-of-care imaging solutions into the bone health space Sep 06, 2022
New Spine Company, NANISX, to Focus on Ambulatory Surgery Centers
NANISX will be divided into two ASC divisions: NANISX Pain, focused on interventional pain management, and NANISX Ortho-Neuro. Sep 06, 2022
